What is SKYE's dilution risk score?

SKYE has a latest available DilutionScore record of 50/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for SKYE, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for SKYE?

DilutionWatch tracks 25 SEC filing types for SKYE including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect SKYE shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For SKYE, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for SKYE tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for SKYE. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

SKYE Dilution Risk Score: 50/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

85

📊 Float Risk

25

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 45%

🔄 Reverse Split model est. 70%

• 50-day avg $0.78 below $1 exchange minimum

• Only 5 months cash — financial pressure

💰 Capital Raise model 35%

• Low cash runway: 5 months remaining

🔔 Track SKYE — Get forecast alerts →

Market Data

Market Cap$27.25M

Shares Outstanding35.42M

Float22.96M

Cash$10.06M

Debt$116.7K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 6.4% shares (2026Q1 vs prior)

41 institutional holders · 17.25M shares

#1 5AM Venture Management, LLC 9.68M shares

#2 Versant Venture Management, LLC 2.01M shares

#3 BAKER BROS. ADVISORS LP 1.58M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.32M

Days to Cover12.6

% of Float5.7%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31

xbrl XBRL WARRANT 2024-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual SKYE Dilution Snapshot

Skye Bioscience, Inc. (SKYE) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for SKYE: xbrl on 2025-12-31; xbrl on 2024-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.